https://rbio.com/news daily 0.75 2026-07-02 https://rbio.com/news/in-the-media/biopharma-apac-rbiolin-preclinical-scale-up monthly 0.5 2025-06-02 https://rbio.com/news/in-the-media/firstword-pharma-rbiolin-insulin-shortage monthly 0.5 2025-06-01 https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/d536e84b-80cb-44ee-b00c-709e662677c4/FirstWord+Pharma+blog+image.png News - FirstWord Pharma: rBIO steps in as big insulin makers scale back legacy products - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://rbio.com/news/press-releases/rbio-addresses-insulin-shortages monthly 0.5 2026-07-02 https://rbio.com/news/in-the-media/bioprocessonline-path-to-insulin-biosimilar monthly 0.5 2025-06-02 https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/2646eeed-18ff-48b4-9c44-b3283d9608dc/BioProcess+Online+article+snapshot.png News - BioProcess Online: The path to producing an insulin biosimilar - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://rbio.com/news/in-the-media/wired-cheap-insulin-rbio monthly 0.5 2025-06-02 https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/e15fd71e-5cb0-4b3a-9aba-91155a1a96ad/Wired+story+snapshot.png News - WIRED: Can a tiny biotech make insulin dirt‑cheap? - Make it stand out Whatever it is, the way you tell your story online can make all the difference. https://rbio.com/news/category/Press+releases monthly 0.5 https://rbio.com/news/category/Insights monthly 0.5 https://rbio.com/news/category/Media+coverage monthly 0.5 https://rbio.com/contact daily 0.75 2026-07-01 https://rbio.com/about daily 0.75 2026-07-02 https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/1744570298794-HWTNJJCEA1EFC1DODQT0/unsplash-image-Ab9Ee6LXLqw.jpg https://rbio.com/home daily 1.0 2026-07-02 https://rbio.com/platform daily 0.75 2026-07-02 https://rbio.com/licensing daily 0.75 2026-07-02 https://rbio.com/investor-top daily 0.75 2026-07-13 https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/f150eb30-1053-4ca8-bde5-24b1b38f54e7/rBIO+lab+equipment.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/065b6076-3afa-4f71-be7e-eb704d11d7a2/5-vials.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/8238ceca-cba5-4ec4-b17b-40f77fb13b55/equals.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/d1a787ef-e01b-44cd-b0dc-4a3cacd8c8ed/IP+platform.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/b65346ce-325d-4e73-959f-dad5fbd9061a/plus.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/710c33c4-3631-4f79-a282-330f024a7f28/rBIO-logo.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/8238ceca-cba5-4ec4-b17b-40f77fb13b55/equals.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/b86103d5-b180-4ad2-9bd8-69c9066f86be/10+vials.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/fb6519b3-8b1d-4590-84e1-6acf464e55ed/Deenadayalan+Bakthavatsalam+-+1+%7C+enhanced.jpeg https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/0c6126c0-30a7-43f0-a653-436cf56909c0/rBIO+Stuart+Douglass+%7C+enhanced-2.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/e8f791ee-0069-4ff9-a9c4-3af497f8fc14/Shawn+Swaney+%7C+enhanced.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/85e192f0-c823-45c7-8de5-ba7e764fba22/Judy+Shizuru-3+%7C+enhanced.jpeg https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/70c37ebb-9c87-45ce-be15-ac5bdae57321/rBIO+Cameron+Owen+%7C+enhanced.jpg https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/fb3f0ec0-65f3-4ab5-9d07-861d09c78e24/global+licensing+market.001.jpeg https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/482c0730-fb9c-475c-a516-b64afdfd3598/rBIO+chart+lady.png https://images.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/363fe3e9-b069-457c-a0a0-ad143692b5a8/moat.png https://video.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/43a21223-a520-44e0-af4b-ca202b09fb99/playlist.m3u8 https://video.squarespace-cdn.com/content/v1/67ec6908d298965924ffe76e/43a21223-a520-44e0-af4b-ca202b09fb99/thumbnail For investors rBIO CEO Dr. Deen Bakthavatsalam explains the company’s insulin manufacturing process and licensing model, which aims to improve the economics of essential peptide drugs.